Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Proving Value Is Eucomed’s Top Priority: An Interview With Guy Lebeau

This article was originally published in The Gray Sheet

Executive Summary

Device makers still have a lot of work to do to convince the cost-conscious governments of Europe that their products have strong socioeconomic value, says Eucomed Chairman Guy Lebeau

You may also be interested in...

U.K. Panel Says: Continue DES Use, But Limit Price Premium Over Bare Metal

The United Kingdom's National Institute of Health and Clinical Excellence has retreated from its August 2007 recommendation that the country's National Health Service stop paying for drug-eluting stents after being bombarded with criticism from interventional cardiologists and stent manufacturers

Industry-Supported Tissue, Device Regs Clear European Union Council

The second of two European Union legislative bodies endorsed two regulations impacting medical device oversight last week

First Research Funded By InHealth Speaks Well For ICDs

Research sponsored by the AdvaMed spin-off InHealth suggests that patients with implanted defibrillators enjoy a quality of life similar to people of the same age without ICDs

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts